Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa-Reference-Cited by-同舟云学术

Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa

Published:2020-12-24 Issue:4 Volume:15 Page:427-435
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Yeh Ming-Lun¹²,Huang Jee-Fu¹²³⁴,Yu Ming-Lung¹²³,Chuang Wan-Long¹²³

Affiliation:

1. Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

2. School of Medicine, Lipid Science and Aging Research Center, and Hepatitis Research Center, College of Medicine, and Center for Cancer Research and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan

3. Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

4. Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

Funder

Kaohsiung Medical University (Center for Cancer Research KMU Global Networking Talent Plan Grant 105KMUOR08), and Kaohsiung Medical University Hospital

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2021.1866985

Reference73 articles.

1. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

2. Time trends of chronic HBV infection over prior decades – A global analysis

3. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis

4. Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma

5. Taiwan consensus statement on the management of chronic hepatitis B

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB;Antiviral Research;2024-06

2. Interferon‐γ⁺ Th1 activates intrahepatic resident memory T cells to promote HBsAg loss by inducing M1 macrophage polarization;Journal of Medical Virology;2024-04-25

3. Suppressors of Cytokine Signaling and Hepatocellular Carcinoma;Cancers;2022-05-22

4. Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts;Wellcome Open Research;2022-05-11

5. Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts;Wellcome Open Research;2022-04-26